Liver involvement in patients with erythropoietic protoporphyria. Issue 4 (April 2022)

• Record Type: Journal Article
• Authors: Wensink, Debby; Coenen, Sandra; Wilson, J.H. Paul; Wagenmakers, Margreet A.E.M.; Langendonk, Janneke G.
• Is Part Of: Digestive and liver disease. Volume 54:Issue 4(2022)
• Page Start: 515
• Page End: 520
• Publication Date: 2022-04
• Subjects: Elastic imaging techniques -- Hepatic steatosis -- Liver stiffness -- Rare diseases complications; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; 616.33005
• DOI: 10.1016/j.dld.2021.08.007
• Languages: English
• ISSNs: 1590-8658

Abstract

Abstract: Background: In erythropoietic protoporphyria (EPP), which presents with severe painful phototoxicity, progressive deposition of protoporphyrins in hepatocytes and bile canaliculi may result in liver disease. Clinically EPP related liver disease ranges from mildly elevated liver enzymes to cirrhosis and acute cholestatic hepatic failure. The prevalence of liver disease in EPP, and factors predicting the risk of developing liver disease, have not been defined in a large series of unselected EPP patients. Aim: To determine the prevalence of liver disease in EPP-patients. Methods: A single-center prospective unselected cohort study of 114 adult EPP patients, who underwent routine laboratory testing, abdominal ultrasonography and transient elastography to assess the presence of steatosis (controlled attenuation parameter, dB/m) and liver stiffness (kPa). Results: 114 adult EPP patients were included. Elevated liver enzymes were found in 6.2% of the patients. Liver steatosis was detected in 29.0%, and significant fibrosis as assessed with liver stiffness measurements was present in 9.6% of patients. BMI positively predicted CAP-values ( p = 0.026); and protoporphyrin IX levels ( p = 0.043) positively predicted liver stiffness. Conclusions: This study demonstrates a prevalence of hepatic steatosis and fibrosis in adult EPP-patients comparable to that found in the general population. Protoporphyrin IX levels correlate with increased liver stiffness in EPP.